GSK Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by GSK Plc, dated February 3, 2025, serves as a notification to the market regarding the Company's total voting rights and capital structure. The data reflects the status as of January 31, 2025, in conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R.
Key Financial Metrics
The filing does not provide financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on capital structure details:
- Issued Share Capital: 4,315,116,636 Ordinary Shares of 31 1/4 pence each.
- Treasury Shares: 169,171,155 Ordinary Shares held in Treasury.
- Total Voting Rights: 4,145,945,481.
Material Changes
The filing text does not provide comparative data against prior periods to identify material changes in share count or voting rights.
Guidance, Outlook, and Risks
This document contains no management commentary, financial guidance, outlook, risk factors, or discussion of contingencies and unusual items. Its sole purpose is to provide the denominator for shareholder interest calculations under FCA rules.
Investor Verification Checklist
- Verify the total number of voting rights (4,145,945,481) for compliance with FCA disclosure thresholds.
- Confirm the number of shares held in Treasury (169,171,155) when calculating free float.
- Ensure the share price and capital value are calculated using the 31 1/4 pence nominal value per share.